Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
Sponsor: Karolinska Institutet
Summary
This is a prospective observational study designed to evaluate Immature Platelet Fraction or Immature Platelet Count and Platelet Function Analyzer-100/200 Closure Time-ADP (in vitro bleeding time) as markers of bleeding risk in thrombocytopenic preterm neonates admitted to the Neonatal Intensive Care Unit.
Official title: The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study-2
Key Details
Gender
All
Age Range
1 Day - Any
Study Type
OBSERVATIONAL
Enrollment
250
Start Date
2021-06-15
Completion Date
2025-12-31
Last Updated
2024-10-09
Healthy Volunteers
No
Conditions
Locations (8)
Boston Children's Hospital
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Intermountain Medical Center
Murray, Utah, United States
Utah Valley Hospital
Provo, Utah, United States
Amsterdam University Medical Centre
Amsterdam, Netherlands
Leiden University Medical Center
Leiden, Netherlands
Karolinska University Hospital Huddinge campus
Huddinge, Sweden
Karolinska University Hospital Solna campus, Astrid Lindgren Children's Hospital
Stockholm, Sweden